Fig. 4From: Tumor microenvironment and immune system preservation in early-stage breast cancer: routes for early recurrence after mastectomy and treatment for lobular and ductal forms of diseaseThe three phases of cancer immunoediting. Normal cells transition to tumour cells expressing specific tumour antigens, calreticulin, and NKG2D ligands if subject to oncogenic mutational transformationBack to article page